Reklama
WIG82 745,58+1,45%
WIG202 436,05+1,72%
EUR / PLN4,31-0,20%
USD / PLN3,99+0,03%
CHF / PLN4,43+0,38%
GBP / PLN5,04+0,04%
EUR / USD1,08-0,24%
DAX18 492,49+0,08%
FT-SE7 952,62+0,26%
CAC 408 205,81+0,01%
DJI39 789,55+0,07%
S&P 5005 252,42+0,07%
ROPA BRENT86,96+1,47%
ROPA WTI83,12+1,71%
ZŁOTO2 220,19+1,30%
SREBRO24,83+1,06%

Masz ciekawy temat? Napisz do nas

twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Farmaceutyczny (far)

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No6/2021
Date of issue:2021-03-01
Short name of the issuer
SOPHARMA AD
Subject
Preliminary consolidated annual financial statements of Sopharma AD for 2020
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Preliminary consolidated annual financial statements of Sopharma AD for 2020
Annexes
FileDescription
SFA_Preliminary_consolidated_financial_statements_2020.rarPreliminary consolidated annual financial statements of Sopharma AD for 2020
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2021-03-01Ognian DonevExecutive Director
Czytaj więcej